Status:
RECRUITING
Postoperative Complications Following Skull Base Tumor Resection
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
Skull Base Tumor
Postoperative Complications
Eligibility:
All Genders
18+ years
Brief Summary
The skull base tumor is located in the deep intracranial layer and is closely related to the brain stem and intracranial nerves. The incidence of postoperative complications after skull base tumor res...
Detailed Description
1. Postoperative pulmonary complications (PPCs), always had a 11.2%-24.6% high incidence rate. Pulmonary ultrasound (LUS), as a non-invasive diagnostic tool, has high accuracy in diagnosing pulmonary ...
Eligibility Criteria
Inclusion
- Age 18 and above
- American Society of Anesthesiologists physical status I to III
- Undergoing elective resection of skull base tumors
- Obtaining written informed consent
Exclusion
- Heart failure, myocarditis, pericarditis, and cardiomyopathy
- Myocardial ischemia less than 6 months old
- Severe arrhythmia
- Severe bradycardia (heart rate below 50 beats per minute)
- Unable to complete preoperative cardiac assessment
- Severe liver dysfunction (Child Pugh C-grade)
- Severe lung diseases
Key Trial Info
Start Date :
September 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT06587906
Start Date
September 10 2024
End Date
September 1 2027
Last Update
February 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital, Capital Medical University
Beijing, China